AIRS · NASDAQ · Medical - Care Facilities

AirSculpt Technologies (AIRS)

Provides private-pay body-contouring procedures through AirSculpt centers in the U.S. and Canada.

$2.47
At close+0.04 (+1.65%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue474848514339394435333943
Cost of revenue171821171615141612141920
Gross profit303027342724252923202123
292816393028272833212223
272616362725242422182323
Selling & marketing70813777106000
General & administrative20072320181614160023
Other expenses33033333103−10
Operating income1111−5−4−4−21−10−2−10
−2−1−2−2−2−2−2−22−1−2−2
Interest expense212222221111
Other non-operating income00000000−3−110
Income before tax−109−6−5−6−3−1−8−2−3−1
Income tax expense153−31−1002−400
Net income from continuing operations−2−56−3−6−5−3−1−101−2−1
Net income−2−56−3−6−5−3−1−101−2−1
EPS, basic−$0.03−$0.08$0.11−$0.06−$0.10−$0.09−$0.05−$0.01−$0.15$0.02−$0.03−$0.02
EPS, diluted−$0.03−$0.08$0.10−$0.06−$0.10−$0.09−$0.05−$0.01−$0.15$0.02−$0.03−$0.02
Weighted average shares, basic575757585858595960606971
Weighted average shares, diluted575758585858595960606971
EBITDA4414−2−1−124−3213
Depreciation & amortization333333333333
EBIT1111−5−4−4−21−6−1−20